Researchers who received funding from Retina UK have carried out experimental gene therapy that is reported to have led to ‘life changing improvements’ to sight for four children with inherited sight loss.
News
The latest news from Retina UK. Please use the filters to find the articles which interest you.
Introducing Splice Bio, a genetic medicines company with some exciting developments for Stargardt’s patients.
Mirugen – Unlocking the Power of Retina Regeneration
Mirugen – Unlocking the Power of Retina Regeneration
Sepul Bio begins clinical trial of ultevursen for USH2A-associated RP
Chris McCausland is heading to Blackpool for week 10 of Strictly Come Dancing.
A recently published study has described numerous disease mechanisms that appear to be common across different types of inherited sight loss, suggesting that there is significant potential for drug treatments that could work regardless of the underlying causative gene.
New stem cell treatment gains approval to enter US clinical trials
New Chair of Trustees
We are delighted to welcome Kathy Evans as our new Chair of Trustees.
A new approach to treating inherited sight loss